Neuropace, Inc. (NPCE) Financials
NPCE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 107.7 million | 87.0 million |
2023-09-30 | 99.3 million | 82.9 million |
2023-06-30 | 102.2 million | 81.0 million |
2023-03-31 | 106.3 million | 78.8 million |
NPCE Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -3.4 million | 2.4 million |
2023-09-30 | -2.3 million | 2.4 million |
2023-06-30 | -4.4 million | 2.7 million |
2023-03-31 | -9.8 million | 2.1 million |
NPCE Net Income
No data available :(
NPCE Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 66.5 million | - | 15.4 million |
2023-09-30 | 61.3 million | - | 15.8 million |
2023-06-30 | 63.6 million | 54.9 million | 16.2 million |
2023-03-31 | 67.6 million | 53.9 million | 16.5 million |
NPCE Shares Outstanding
NPCE Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 32000 | 5.4 million | 13.2 million | - |
2023-09-30 | 9000 | 4.8 million | 13.4 million | - |
2023-06-30 | - | 5.3 million | 14.5 million | - |
2023-03-31 | 132000 | 5.3 million | 13.4 million | - |
NPCE Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 18.0 million | 4.5 million |
2023-09-30 | 16.4 million | 4.2 million |
2023-06-30 | 16.5 million | 4.5 million |
2023-03-31 | 14.5 million | 4.1 million |
NPCE
Price: $13.64
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -10.80
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Volume: 24800
Market Capitalization: 391.7 million